Development and Reproduction (한국발생생물학회지:발생과생식)

The Korean Society of Developmental Biology (한국발생생물학회)
권호 표지
DOI QR코드

DOI QR Code

Constitutive Activating Eel Luteinizing Hormone Receptors Induce Constitutively Signal Transduction and Inactivating Mutants Impair Biological Activity

  • Byambaragchaa, Munkhzaya (Institute of Genetic Engineering, Hankyong National University) ;
  • Choi, Seung-Hee (School of Animal Life Convergence Science, Hankyong National University) ;
  • Kim, Dong-Wan (Institute of Genetic Engineering, Hankyong National University) ;
  • Min, Kwan-Sik (Institute of Genetic Engineering, Hankyong National University)
  • Received : 2021.05.31
  • Accepted : 2021.08.25
  • Published : 2021.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

In contrast to the human lutropin receptor (hLHR) and rat LHR (rLHR), very few naturally occurring mutants in other mammalian species have been identified. The present study aimed to delineate the mechanism of signal transduction by three constitutively activating mutants (designated M410T, L469R, and D590Y) and two inactivating mutants (D383N and Y546F) of the eel LHR, known to be naturally occurring in human LHR transmembrane domains. The mutants were constructed and measured cyclic adenosine monophosphate (cAMP) accumulation via homogeneous time-resolved fluorescence assays in Chinese hamster ovary (CHO)-K1 cells. The activating mutant cells expressing eel LHR-M410T, L469R, and D590Y exhibited a 4.0-, 19.1-, and 7.8-fold increase in basal cAMP response without agonist treatment, respectively. However, inactivating mutant cells expressing D417N and Y558F did not completely impaired signal transduction. Specifically, signal transduction in the cells expressing activating mutant L469R was not occurred with a further ligand stimulation, showing that the maximal response exhibited approximately 53% of those of wild type receptor. Our results suggested that the constitutively activating mutants of the eel LHR consistently occurred without agonist treatment. These results provide important information of LHR function in fish and regulation with regard to mutations of highly conserved amino acids in glycoprotein hormone receptors.

Keywords

References

  1. Althumairy D, Zhang X, Baez N, Barisas G, Roess DA, Bousfield GR, Crans DC (2020) Glycoprotein G-protein coupled receptors in disease: Luteinizing hormone receptors and follicle stimulating hormone receptors. Diseases 8:35. https://doi.org/10.3390/diseases8030035
  2. Ascoli M, Fanelli F, Segaloff DL (2002) The lutropin/choriogonadotropin gonadotropin receptor, a 2002 perspective. Endocr Rev 23:141-174. https://doi.org/10.1210/er.23.2.141
  3. Byambaragchaa M, Kim DJ, Kang MH, Min KS (2018) Site specificity of eel luteinizing hormone N-linked oligosaccharides in signal transduction. Gen Comp Endocrinol 268:50-56. https://doi.org/10.1016/j.ygcen.2018.07.015
  4. Byambaragchaa M, Kim JS, Park HK, Kim DJ, Hong SM, Kang MH, Min KS (2020) Constitutive activation and inactivation of mutations inducing cell surface loss of receptor and impairing of signal transduction of agonist-stimulated eel follicle-stimulating hormone receptor. Int J Mol Sci 21:7075. https://doi.org/10.3390/ijms21197075
  5. Dhanwada KR, Vijapurkar U, Ascoli M (1996) Two mutations of the lutropin/choriogonadotropin receptor that impair signal transduction also interfere with receptor-mediated endocytosis. Mol Endocrinol 10:544-554. https://doi.org/10.1210/mend.10.5.8732685
  6. Galet C, Ascoli M (2006) A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation. Mol Endocrinol 20:2931-2945. https://doi.org/10.1210/me.2006-0138
  7. Huhtaniemi I (2000) Activating and inactivating hormone receptor mutations. Horm Res 53:S9-S16.
  8. Huhtaniemi IT, Themmen AP (2005) Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 26:207-217. https://doi.org/10.1385/ENDO:26:3:207
  9. Ignacak M, Hilczer M, Zarzycki J, Trzeciak WH (2000) Substitution of M398T in the second transmembrane helix of the LH receptor in a patient with familial male-limited precocious puberty. Endocr J 47:595-599. https://doi.org/10.1507/endocrj.47.595
  10. Kim DJ, Park CW, Kim DW, Park HK, Byambaragchaa M, Lee NS, Hong SM, Seo MY, Kang MH, Min KS (2016) Production and characterization of monoclonal antibodies against recombinant tethered follicle-stimulating hormone from Japanese eel Anguilla japonica. Gen Comp Endocrinol 233:8-15. https://doi.org/10.1016/j.ygcen.2016.04.030
  11. Kim JM, Munkhuu O, Byambaragchaa M, Lee BI, Kim SK, Kang MH, Kim DJ, Min KS (2019) Site-specific roles of N-linked oligosaccharides in recombinant eel follicle-stimulating hormone for secretion and signal transduction. Gen Comp Endocrinol 276:37-44. https://doi.org/10.1016/j.ygcen.2019.03.003
  12. Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, Grootegoed JA, Themmen AP (1995) A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 80:3168-3172. https://doi.org/10.1210/jcem.80.11.7593421
  13. Kudo M, Osuga Y, Kobilka BK, Hsueh AJ (1996) Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J Biol Chem 271:22470-22478. https://doi.org/10.1074/jbc.271.37.22470
  14. Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, Segaloff DL (1998) A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442-450. https://doi.org/10.1210/mend.12.3.0077
  15. Latronico AC, Segaloff DL (2007) Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor. Mol Cell Endocrinol 260-262:287-293. https://doi.org/10.1016/j.mce.2005.11.053
  16. McGee SR, Narayan P (2013) Precocious puberty and Leydig cell hyperplasia in male mice with a gain of function mutation in the LH receptor gene. Endocrinology 154:3900-3913. https://doi.org/10.1210/en.2012-2179
  17. Meehan TP, Narayan P (2007) Constitutively active luteinizing hormone receptors: Consequences of in vivo expression. Mol Cell Endocrinol 260-262:294-300. https://doi.org/10.1016/j.mce.2006.03.045
  18. Min KS, Liu X, Fabritz J, Jaquette J, Abell AN, Ascoli M (1998) Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agoniststimulated internalization of the lutropin/choriogonadotropin receptor. J Biol Chem 273:34911-34919. https://doi.org/10.1074/jbc.273.52.34911
  19. Quintana J, Wang H, Ascoli M (1993) The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors. Mol Endocrinol 7:767-775. https://doi.org/10.1210/mend.7.6.8395653
  20. Segaloff DL, Ascoli M (1993) The lutropin/choriogonadotropin receptor... 4 years later. Endocr Rev 14:324-347. https://doi.org/10.1210/er.14.3.324
  21. Shenker A (2002) Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty. Recept Channels 8:3-18. https://doi.org/10.1080/10606820212138
  22. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654. https://doi.org/10.1038/365652a0
  23. Tao YX (2006) Inactivating mutations of G protein-coupled receptors and diseases: Structure-function insights and therapeutic implications. Pharmacol Ther 111:949-973. https://doi.org/10.1016/j.pharmthera.2006.02.008
  24. Tao YX, Abell AN, Liu X, Nakamura K, Segaloff DL (2000) Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III. Mol Endocrinol 14:1272-1282. https://doi.org/10.1210/mend.14.8.0503
  25. Wu SM, Leschek EW, Rennert OM, Chan WY (2000) Luteinizing hormone receptor mutations in disorders of sexual development and cancer. Front Biosci 5:D343-D352.
  26. Yano K, Kohn LD, Saji M, Kataoka N, Okuno A, Cutler GB Jr (1996) A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. Biochem Biophys Res Commun 220:1036-1042. https://doi.org/10.1006/bbrc.1996.0528
  27. Zhang M, Mizrachi D, Fanelli F, Segaloff DL (2005) The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor. J Biol Chem 280:26169-26176. https://doi.org/10.1074/jbc.M502102200
  28. Zhang M, Tao YX, Ryan GL, Feng X, Fanelli F, Segaloff DL (2007) Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J Biol Chem 282:25527-25539. https://doi.org/10.1074/jbc.M703500200